Reported 23 days ago
Bausch + Lomb Corp. experienced a significant increase in its stock price following news that the eye-care company is considering a sale to alleviate financial ties to its heavily indebted parent, Bausch Health. The company is reportedly collaborating with Goldman Sachs to assess buyer interest, with estimates valuing Bausch + Lomb at over $13 billion. This move is seen as favorable to investors concerned about the financial entanglements of Bausch Health, which also faces substantial debt.
Source: YAHOO